Skip to content

Clinical trials

Completed Lupus Erythematosus, Systemic trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Completed Country / region: Chile Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20103
20114
20121
20131
20151
20163
20171
20182
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthera Pharmaceuticals2
Eli Lilly and Company2
Human Genome Sciences Inc., a GSK Company2
MedImmune LLC2
Ablynx, a Sanofi company1
EMD Serono1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
GlaxoSmithKline1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic21
Autoimmune Diseases7
Connective Tissue Diseases2
Dermatomyositis1
Immune System Diseases1
Lupus Erythematosus, Cutaneous1
Lupus Erythematosus, Discoid1
Raynaud Disease1
Scleroderma, Diffuse1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.